---
document_datetime: 2024-10-16 11:33:56
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/reyataz-epar-all-authorised-presentations_en.pdf
document_name: reyataz-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.1295216
conversion_datetime: 2025-12-22 13:18:32.19848
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical form   | Route of administration   | Immediate Packaging    | Pack size                   |
|------------------|-------------------|------------|-----------------------|---------------------------|------------------------|-----------------------------|
| EU/1/03/267/005  | Reyataz           | 200 mg     | Capsule, hard         | Oral use                  | bottle (HDPE)          | 60 capsules                 |
| EU/1/03/267/006  | Reyataz           | 200 mg     | Capsule, hard         | Oral use                  | blister (alu/alu)      | 60 x 1 capsules (unit dose) |
| EU/1/03/267/008  | Reyataz           | 300 mg     | Capsule, hard         | Oral use                  | bottle (HDPE)          | 30 capsules                 |
| EU/1/03/267/009  | Reyataz           | 300 mg     | Capsule, hard         | Oral use                  | blister (alu/alu)      | 30 x 1 capsules (unit dose) |
| EU/1/03/267/010  | Reyataz           | 300 mg     | Capsule, hard         | Oral use                  | bottle (HDPE)          | 90 (3 x 30) capsules        |
| EU/1/03/267/011  | Reyataz           | 200 mg     | Capsule, hard         | Oral use                  | bottle (HDPE)          | 180 (3 x 60) capsules       |
| EU/1/03/267/012  | Reyataz           | 50 mg      | Oral powder           | Oral use                  | sachet (PET/alu/LLDPE) | 30 sachets                  |